Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Allergy and Immunology
Trial Title   Open-label Patient Continuation of DX-88 (Ecallantide) for acute Hereditary Angioedema (HAE) Attacks
Description of Research   The purpose of this study is to determine the efficacy and safety of an experimental drug, DX-88, in the treatment of acute attacks of hereditary angioedema (HAE) in patients who are not eligible to enroll in any other DX-88 protocol.
Study Number   HSR 07-0791
Inclusion/Notes   Age 10 or older
History of HAE
Additional screening criteria
Principal Investigator   Leflein MD, Jeffrey
Contact Name   Lezak, Pat
Fax   (734) 434-6317
Phone   (734) 434-3007
A Member of Trinity Health
© 2015 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456